Cancer drug starts clinical trials in human brain-cancer patients
A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain. This phase Ib trial will determine if the experimental drug PAC-1 can be used safely in combination with a standard brain-cancer chemotherapy drug, temozolomide.
Study in mice finds dietary levels of genistein may adversely affect female fertility
Exposure to the phytoestrogen genistein prior to conception may adversely affect female fertility and pregnancy outcomes, depending on the dosage and duration of exposure, a new study in mice by scientists at the University of Illinois suggests.
Paper: Clinical signs best predictors of mortality in critically ill calves
Clinical signs may be better predictors of mortality in neonatal calves with diarrhea than blood pH levels and other laboratory findings, suggests a new study co-written by University of Illinois researcher Peter D. Constable.
Fred A. Kummerow, successful crusader against trans fats, dies at 102
Fred A. Kummerow, a pioneer in the study of dietary contributors to heart disease who led a decades-long crusade to remove trans fats from the food supply, died Wednesday, May 31, at his home in Urbana, Illinois. He was 102.